塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/28 | 7,177 | 7,200 | 7,097 | 7,116 | -61 | -0.8% | 1,085,800 |
2019/02/27 | 7,140 | 7,177 | 7,084 | 7,177 | +64 | +0.9% | 1,365,200 |
2019/02/26 | 7,072 | 7,161 | 7,064 | 7,113 | -8 | -0.1% | 844,800 |
2019/02/25 | 7,064 | 7,121 | 7,025 | 7,121 | +107 | +1.5% | 986,500 |
2019/02/22 | 7,046 | 7,072 | 6,987 | 7,014 | +2 | ±0% | 855,600 |
2019/02/21 | 7,017 | 7,070 | 6,938 | 7,012 | +16 | +0.2% | 1,011,400 |
2019/02/20 | 6,962 | 7,043 | 6,958 | 6,996 | +30 | +0.4% | 1,062,600 |
2019/02/19 | 6,933 | 6,999 | 6,880 | 6,966 | +12 | +0.2% | 873,900 |
2019/02/18 | 6,849 | 6,992 | 6,849 | 6,954 | +105 | +1.5% | 1,081,300 |
2019/02/15 | 6,724 | 6,849 | 6,723 | 6,849 | +125 | +1.9% | 1,284,400 |
2019/02/14 | 6,699 | 6,766 | 6,682 | 6,724 | +15 | +0.2% | 900,800 |
2019/02/13 | 6,751 | 6,770 | 6,698 | 6,709 | -47 | -0.7% | 979,400 |
2019/02/12 | 6,519 | 6,763 | 6,515 | 6,756 | +304 | +4.7% | 1,370,200 |
2019/02/08 | 6,553 | 6,592 | 6,448 | 6,452 | -179 | -2.7% | 1,236,700 |
2019/02/07 | 6,666 | 6,677 | 6,556 | 6,631 | -35 | -0.5% | 880,600 |
2019/02/06 | 6,784 | 6,840 | 6,658 | 6,666 | -54 | -0.8% | 1,509,500 |
2019/02/05 | 6,801 | 6,826 | 6,676 | 6,720 | -138 | -2% | 1,373,800 |
2019/02/04 | 6,832 | 6,929 | 6,830 | 6,858 | +118 | +1.8% | 1,259,500 |
2019/02/01 | 6,711 | 6,789 | 6,671 | 6,740 | +54 | +0.8% | 1,261,100 |
2019/01/31 | 6,628 | 6,704 | 6,565 | 6,686 | +77 | +1.2% | 1,862,700 |
2019/01/30 | 6,612 | 6,624 | 6,530 | 6,609 | -45 | -0.7% | 1,220,600 |
2019/01/29 | 6,503 | 6,654 | 6,492 | 6,654 | +149 | +2.3% | 1,373,100 |
2019/01/28 | 6,400 | 6,556 | 6,386 | 6,505 | +55 | +0.9% | 1,095,200 |
2019/01/25 | 6,620 | 6,623 | 6,450 | 6,450 | -165 | -2.5% | 1,850,400 |
2019/01/24 | 6,560 | 6,618 | 6,521 | 6,615 | +19 | +0.3% | 1,045,100 |
2019/01/23 | 6,553 | 6,603 | 6,540 | 6,596 | +43 | +0.7% | 1,179,000 |
2019/01/22 | 6,601 | 6,615 | 6,513 | 6,553 | -37 | -0.6% | 899,800 |
2019/01/21 | 6,700 | 6,700 | 6,565 | 6,590 | -11 | -0.2% | 1,151,400 |
2019/01/18 | 6,563 | 6,623 | 6,515 | 6,601 | +131 | +2% | 1,161,600 |
2019/01/17 | 6,515 | 6,606 | 6,404 | 6,470 | +30 | +0.5% | 1,086,000 |
2019/01/16 | 6,489 | 6,499 | 6,380 | 6,440 | +67 | +1.1% | 1,057,000 |
2019/01/15 | 6,360 | 6,478 | 6,335 | 6,373 | +30 | +0.5% | 1,353,700 |
2019/01/11 | 6,427 | 6,461 | 6,342 | 6,343 | -40 | -0.6% | 1,305,500 |
2019/01/10 | 6,450 | 6,450 | 6,355 | 6,383 | -85 | -1.3% | 957,800 |
2019/01/09 | 6,447 | 6,524 | 6,443 | 6,468 | +37 | +0.6% | 1,062,500 |
2019/01/08 | 6,447 | 6,490 | 6,368 | 6,431 | +63 | +1% | 1,343,100 |
2019/01/07 | 6,508 | 6,519 | 6,349 | 6,368 | +94 | +1.5% | 1,140,900 |
2019/01/04 | 6,175 | 6,292 | 6,114 | 6,274 | +3 | ±0% | 1,419,500 |
2018/12/28 | 6,379 | 6,390 | 6,257 | 6,271 | -114 | -1.8% | 960,000 |
2018/12/27 | 6,358 | 6,460 | 6,273 | 6,385 | +218 | +3.5% | 1,597,500 |
2018/12/26 | 6,183 | 6,250 | 6,055 | 6,167 | +54 | +0.9% | 1,277,800 |
2018/12/25 | 6,177 | 6,211 | 6,092 | 6,113 | -356 | -5.5% | 1,574,400 |
2018/12/21 | 6,443 | 6,542 | 6,396 | 6,469 | -11 | -0.2% | 2,102,200 |
2018/12/20 | 6,562 | 6,642 | 6,446 | 6,480 | -190 | -2.8% | 1,656,300 |
2018/12/19 | 6,700 | 6,739 | 6,612 | 6,670 | -122 | -1.8% | 1,580,200 |
2018/12/18 | 6,937 | 6,995 | 6,792 | 6,792 | -223 | -3.2% | 1,705,500 |
2018/12/17 | 7,038 | 7,097 | 6,963 | 7,015 | -21 | -0.3% | 1,139,000 |
2018/12/14 | 7,054 | 7,174 | 7,020 | 7,036 | -87 | -1.2% | 2,148,000 |
2018/12/13 | 7,142 | 7,177 | 7,081 | 7,123 | +32 | +0.5% | 1,217,100 |
2018/12/12 | 6,961 | 7,095 | 6,915 | 7,091 | +285 | +4.2% | 1,736,200 |
1401~
1450
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム